EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Long‐term mutational analysis, clonal metrics, and dynamics in patients with chronic idiopathic neutropenia

Grigorios Tsaknakis, Irene Mavroudi, Marco Roncador iD, Anna Maria Perantonaki iD, Erasmia Boutakoglou, Stavros Papadakis iD, Anna Gallì, Stamatia Laidou, Charalampos Pontikoglou iD, Anastasia Chatzidimitriou iD, Luca Malcovati iD, Helen A Papadaki iD

HemaSphere · 2026-10 · 10 (10)

DOI: 10.1002/hem3.70496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HemaSphere, online erschienen am 06.10.2026. Verfasst von Grigorios Tsaknakis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, University Hospital of Heraklion, and Hemopoiesis Research Laboratory, School of Medicine University of Crete Heraklion Gre…. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Characterization of the presence and evolution of clonal hematopoiesis (CH) in patients with unexplained cytopenias is fundamental to risk‐stratifying patients and optimizing clinical surveillance for malignant progression. We investigated the mutational spectrum and clonal metrics in a cohort of 256 patients with chronic idiopathic neutropenia (CIN)—clinically overlapping with idiopathic cytopenia of undetermined significance with isolated neutropenia (ICUS‐N)—and assessed clonal presence and dynamics through longitudinal tracking of 104 patients with a median follow‐up of 32 months. CH was identified in 12.5% of patients, primarily involving single DNMT3A or TET2 mutations. Longitudinal analysis revealed two distinct mutational patterns: an age‐related pattern, predominantly involving DNMT3A and TET2 single mutations, which showed marginal changes in clone size and associated with stable disease course, and a high‐risk pattern, primarily driven by SRSF2 and IDH1/2 mutations, characterized by higher clonal expansion and a high risk of malignant progression. Malignant transformation in CIN was significantly associated with baseline variant allele frequency (VAF) (VAF > 10%), the presence of multiple mutations, and detection of specific driver mutations ( SRSF2 , IDH1/2 ). An annual VAF increase (ΔVAF/year) ≥7.5% was found to optimally predict evolution, thus showing that clonal dynamics can serve as an indicator of disease outcome. Longitudinal assessment of peripheral blood hematologic parameters was found not to display clinically significant changes. These findings provide important insight into high‐risk evolutionary patterns in CIN and underscore the importance of longitudinal monitoring with next‐generation sequencing (NGS) for clinical decision‐making and risk‐adapted management in CIN patients with clonal cytopenia.

Autor:innen und Institutionen

  • Department of Hematology, University Hospital of Heraklion, and Hemopoiesis Research Laboratory, School of Medicine University of Crete Heraklion Greece.
  • Unit of Molecular Hematology and Precision Medicine IRCCS Fondazione Policlinico San Matteo Pavia Italy.
  • Department of Medical Oncology and Hematology University Hospital Zurich Zurich Switzerland.
  • Department of Molecular Medicine University of Pavia Pavia Italy.
  • Institute of Applied Biosciences, Centre for Research and Technology Hellas Thessaloniki Greece.

ORCID-Profile: Marco Roncador, Anna Maria Perantonaki, Stavros Papadakis, Charalampos Pontikoglou, Anastasia Chatzidimitriou, Luca Malcovati, Helen A Papadaki

Zitieren

APA

Tsaknakis, G., Mavroudi, I., Roncador, M., Perantonaki, A. M., Boutakoglou, E., Papadakis, S., Gallì, A., Laidou, S., Pontikoglou, C., Chatzidimitriou, A., Malcovati, L., & Papadaki, H. A. (2026). Long‐term mutational analysis, clonal metrics, and dynamics in patients with chronic idiopathic neutropenia. HemaSphere, 10(10). https://doi.org/10.1002/hem3.70496

Vancouver

Tsaknakis G, Mavroudi I, Roncador M, Perantonaki AM, Boutakoglou E, Papadakis S, et al. Long‐term mutational analysis, clonal metrics, and dynamics in patients with chronic idiopathic neutropenia. HemaSphere. 2026;10(10). doi:10.1002/hem3.70496

BibTeX
@article{Tsaknakis2026,
  author = {Tsaknakis, Grigorios and Mavroudi, Irene and Roncador, Marco and Perantonaki, Anna Maria and Boutakoglou, Erasmia and Papadakis, Stavros and Gallì, Anna and Laidou, Stamatia and Pontikoglou, Charalampos and Chatzidimitriou, Anastasia and Malcovati, Luca and Papadaki, Helen A},
  title = {Long‐term mutational analysis, clonal metrics, and dynamics in patients with chronic idiopathic neutropenia},
  journal = {HemaSphere},
  year = {2026},
  volume = {10},
  number = {10},
  doi = {10.1002/hem3.70496}
}
Kostenlos starten →